semaglutide and eating disorders rise amid popular weight loss medications Wegovy Zepbound—Is there a link? New hope for binge eating

See additional terms and conditions for Chegg Study or Chegg Study Pack on Chegg.com Show transcribed image text Question: Semaglutide differs from GLP-1 in just two amino acids where modifications were made to increase the half-life of the peptide drug in the body and minimize the drug's immunogenicity

For example, concurrent use with corticosteroids may amplify the potential for fluid retention or electrolyte imbalance, particularly sodium and water retention

A 2023 pharmacokinetic study published in Diabetes, Obesity and Metabolism confirmed that semaglutide delays gastric half-emptying time by approximately 33% at steady state [1]

Frequently Asked Questions How is a medical weight loss program different from commercial diet programs